|
|
|||||||
 |
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
03-12-2016, 06:31 AM
|
|||
|
|||
UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug
LONDON, March 11 (Reuters) - European and U.S. regulators are reviewing the safety of Gilead Sciences' leukaemia drug Zydelig due to concerns over serious adverse events, including deaths.  ??????? ??????: UPDATE 1-Infection worries prompt regulatory reviews of Gilead leukaemia drug || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
|
العرض العادي
